StockData

electroCore vs Myomo

ECOR and MYO side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ECOR and MYO compare

electroCore is the larger company, worth 1.2 times as much as Myomo ($43.2M against $36.4M).

electroCore grew revenue faster over the last twelve months (33.5% versus 6.1% for Myomo).

Myomo keeps more of each dollar of sales as profit, with a net margin of −33.5% compared with −40.0% at electroCore.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricECORMYO
Size and price
Market cap$43.2M$36.4M
Share price$4.79$0.919
Change, 1 year−14.5%12.6%
Change, 5 years−58.0%−89.2%
Beta (5Y)2.383.01
Employees83184
StockData Score
Total score77
Valuation score12 (better)
Growth score4 (better)2
Performance score11
Health score12 (better)
Dividend score00
Valuation
P/S1.2×0.8× (better)
P/B–6.2×
FCF yield−22.6% (better)−22.9%
Fair value–$1.31
Margin of safety–29.9%
Growth
Revenue growth (TTM)33.5% (better)6.1%
Revenue growth, 5Y average55.7% (better)40.1%
Profitability
Gross margin87.1% (better)68.4%
Operating margin−37.6%−27.1% (better)
Net margin−40.0%−33.5% (better)
FCF margin−26.4%−19.2% (better)
Return on equity–−124%
Financial health
Debt / equity–0.08
Interest coverage−1095.5×–
Current ratio1.212.31 (better)
Altman Z-score−15.41−3.64 (better)
Piotroski F-score33
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions11.4%30.8%
Held by insiders16.7%16.3%
Insider net buying, 12 months−$667K$203K (better)
Short interest, % of float4.8%3.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.